white Surgenex logo

Pioneering the future of Biologic Medical Solutions

Surgenex® is committed to turning innovative scientific research into industry leading human cellular and tissue-based products.

The Surgenex®

checkmark icon


The patented Excellion® process is used to produce the highest quality allograft tissues using tightly controlled surgical procedures.

checkmark icon


Surgenex® prides itself on exceeding regulatory safety standards through rigorous quality processes and third-party serological testing.

checkmark icon


With unprecedented service and care for providers and their patients our staff is dedicated to providing the very best at a competitive price.


Birth Tissue Allografts

Dehydrated, terminally irradiated membranes available in multiple configurations and sizes

Learn More

Bone Matrix Implants

Orthobiologic allografts processed to preserve the native biomechanical structure of the tissue

Learn More

Acellular Dermal Matrix

Decellularized and processed to preserve the biological properties that promote revascularization and repair

Learn More

Dentistry Allografts

Allograft solutions supporting implant and reconstructive dentistry

Learn More

Structural Allografts

Precision milled structural allografts to support spinal and foot & ankle surgery

Learn More

Clinical Evaluation

In vitro, in vivo, and clinical evaluation

Learn More

Analytical Development

Custom analytical development for characterization and lot release testing

Learn More

Verification & Validation

Process and product verification and validation

Learn More

Formulation Optimization

Formulation optimization for manufacturing

Learn More

Product Development

Full product and process development from concept to commercialization

Learn More

Custom Processing

Technology in-transfer and custom processing

Learn More

Patented Processes Yield Superior Results

Learn More

Tissue Procurement

All tissue goes through extensive donor screening and is solely procured by FDA registered tissue banks.


Through tightly controlled surgical procedures the tissue is cleaned, processed, and stored to maximize its therapeutic benefits.


Each product is carefully inspected by our Quality Assurance Team and stored in a controlled and monitored environment to ensure quality and longevity.



Harnessing the power of the amniotic membrane's natural properties to provide a protective covering in a variety of therapeutic applications.

Learn More


Harnessing the power of the amniotic membrane's natural properties to provide a protective covering for use in ophthalmic applications.

Learn More


Harnessing the power of orthobiologic allografts to promote new bone formation in a variety of therapeutic applications.

Learn More
left arrow icon
right arrow icon


Surgenex CCO Mark Diaz
Mark Diaz
President & CCO

Delivering Customer-Centric Solutions

Mr. Diaz has over 30 years of sales, commercial operations and executive leadership experience in the biologics and medical device industries.  He has worked at both public and private companies including Matria Healthcare, MiMedx and BioIQ.

Through his career, Mr. Diaz has led negotiations on multi-year, multimillion-dollar contracts with GPOs and IDNs and many Fortune 500 companies.  He obtained a Master of International Management from Schiller International University, a Bachelor of Science in International Affairs from Florida State University and is a Six Sigma Green Belt.  He lived in Europe for 16 years and speaks German.

Surgenex CFO Dan Robinson
Dan Robinson

Focused on Value & Accelerated Growth

Mr. Robinson has nearly two decades of Private Equity and Venture Capital experience in CFO and Controller roles including previous experience working with tissue banks.

Mr. Robinson has worked closely with many entrepreneurs through rapid growth cycles and M&A transaction.  Mr. Robinson has a BS of Accounting and Business Management, and an MBA degree. He is also a Certified Valuation Analyst (CVA), and a Certified Merger and Acquisition Advisor (CM&AA).

Surgenex CQRO
Jackie Warn

Ensuring Rigorous Quality In Every Step

Ms. Warn, recognized for her strategic leadership, boasts nearly three decades of experience in quality, regulatory, and performance excellence across various sectors including biotechnology, tissue banking, hospitals, and laboratories. Her expertise lies in developing and spearheading enterprise-wide regulatory affairs and quality management systems, ensuring rigorous adherence to the highest regulatory standards while driving operational process enhancements.

Ms. Warn actively contributes to the field by serving on various committees and councils within the American Association of Tissue Banks.. Her educational background includes an MBA, a BS in Business Administration, and an AAS in Medical Laboratory Technology. Additionally, she is certified by the American Society of Quality (CMQOE) and the American Society of Clinical Pathologists (MLT).